STOCK TITAN

POMDOCTOR (POM) names HYYH CPA LLC as new independent auditor

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

POMDOCTOR LIMITED has changed its independent registered public accounting firm. On April 20, 2026, the company dismissed Marcum Asia CPAs LLP and appointed HYYH CPA LLC to audit its consolidated financial statements for the year ended December 31, 2025.

The company states there were no disagreements with Marcum on accounting principles, financial statement disclosure, or audit scope for the years ended December 31, 2023 and 2024, and no reportable events other than previously disclosed material weaknesses in internal control over financial reporting. These weaknesses include insufficient U.S. GAAP/SEC expertise, incomplete financial reporting policies and procedures, and weaknesses in system access security and change management.

Positive

  • None.

Negative

  • None.

Insights

POMDOCTOR switches auditors with no reported disputes but retains disclosed control weaknesses.

POMDOCTOR LIMITED has replaced Marcum Asia CPAs LLP with HYYH CPA LLC as independent auditor for the year ended December 31, 2025. The company notes that Marcum’s prior opinions for 2023 and 2024 were clean, without adverse or qualified language on accounting principles or audit scope.

The filing explicitly states there were no disagreements or other reportable events with Marcum beyond previously disclosed material weaknesses in internal control over financial reporting. These relate to limited U.S. GAAP/SEC expertise, incomplete reporting policies, and IT access and change-management controls, which remain areas of focus as HYYH takes over.

Auditor change date April 20, 2026 Effective date of dismissal of Marcum and appointment of HYYH
Audit year for HYYH Year ended December 31, 2025 Period HYYH is engaged to audit and report on
Prior audited years by Marcum Years ended December 31, 2023 and 2024 Marcum’s clean audit reports without adverse or qualified opinions
Prospectus reference date October 9, 2025 Date of prospectus describing material weaknesses in internal control
independent registered public accounting firm financial
"dismissed Marcum Asia CPAs LLP (“Marcum”) as its independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
material weaknesses financial
"other than the material weaknesses identified in the Company’s internal control over financial reporting"
Material weaknesses are significant flaws in a company’s systems for ensuring its financial reports are accurate and reliable. Like a broken lock on a safe, they increase the chance that financial statements contain big errors or omissions, which can mislead investors about performance and risk; discovering one often raises questions about management oversight, may lead to restated results, and can affect investor confidence and a company’s valuation.
internal control over financial reporting financial
"material weaknesses identified in the Company’s internal control over financial reporting"
Internal control over financial reporting is a company’s system of procedures and checks designed to make sure its financial statements are accurate and complete, like a set of guardrails and verification steps that catch mistakes or fraud before numbers are published. Investors care because strong controls make reported results more trustworthy, lower the risk of surprise restatements or regulatory problems, and give greater confidence when valuing the company or comparing it to peers.
U.S. GAAP financial
"requisite knowledge and experience in application of U.S. GAAP and SEC rules"
U.S. GAAP is a set of rules and standards that companies in the United States follow to prepare their financial reports. It helps ensure that financial information is consistent and clear, so investors and others can compare and understand a company's financial health easily.
Form 20-F regulatory
"as that term is defined in Item 16F(a)(1)(iv) of Form 20-F"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of April 2026

 

Commission file number: 001-42749

 

 

 

POMDOCTOR LIMITED

 

 

 

Yongxu Industrial Park
No.19-23 Hejing Road, Dongsha Street
Liwan District, Guangzhou 510000

People’s Republic of China

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F    Form 40-F

 

 

 

 

 

Change of Independent Registered Public Accounting Firm

 

On April 20, 2026, POMDOCTOR LIMITED (the “Company”) dismissed Marcum Asia CPAs LLP (“Marcum”) as its independent registered public accounting firm. The Company has appointed HYYH CPA. LLC (“HYYH”) as its independent registered public accounting firm, effective on April 20, 2026. The change of the independent registered public accounting firm was made after a careful consideration and evaluation process by the Company, and has been approved by the Company’s board of directors and the audit committee. HYYH is engaged to audit and report on the consolidated financial statements of the Company as of and for the year ended December 31, 2025. The audit report of Marcum on the consolidated financial statements of the Company for the fiscal years ended December 31, 2023 and 2024 did not contain any adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles.

 

During the fiscal years ended December 31, 2023 and 2024, and the subsequent interim period through April 20, 2026, there were no: (1) “disagreements” (as that term is defined in Item 16F(a)(1)(iv) of Form 20-F and the related instructions) between the Company and Marcum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Marcum, would have caused Marcum to make reference to the subject matter of the disagreements in connection with its report on the Company’s consolidated financial statements, or (2) reportable events as set forth in Item 16F(a)(1)(v)(A) through (D) of Form 20-F, other than the material weaknesses identified in the Company’s internal control over financial reporting as reported on its prospectus filed under Rule 424(b)(4) with the Securities and Exchange Commission (the “SEC”) on October 9, 2025. Such material weaknesses related to the Company’s (i) lack of sufficient accounting and financial reporting personnel with requisite knowledge and experience in application of U.S. GAAP and SEC rules, (ii) lack of financial reporting policies and procedures that are commensurate with U.S. GAAP and SEC reporting requirements, and (iii) lack of proper control of the Company’s system logical access security and system change management.

 

During the Company’s fiscal years ended December 31, 2023 and 2024 and through the date of the engagement of HYYH, neither the Company nor anyone on its behalf has consulted with HYYH on either (a) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and neither a written report nor oral advice was provided to the Company by HYYH which HYYH concluded as an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (b) any matter that was the subject of a disagreement (as that term is defined in Item 16F(a)(1)(iv) of Form 20-F and the related instructions thereto) or a reportable event (as set forth in Item 16F(a)(1)(v)(A) through (D) of Form 20-F).

 

The Company provided Marcum with a copy of the disclosures it is making in this report on Form 6-K and requested that Marcum furnish a letter addressed to the SEC stating whether or not it agrees with the statements made herein. A copy of Marcum’s letter, dated April 20, 2026, is attached as Exhibit 16.1 to this report on Form 6-K.

 

The Company intends to use this Form 6-K and the accompanying exhibit to satisfy its reporting obligations under Item 16F(a) of its Form 20-F for the year ended December 31, 2025 to the extent provided in and permitted by Paragraph 2 of the Instructions to Item 16F of Form 20-F and plans to incorporate Exhibit 16.1 by reference into such Form 20-F to the extent necessary to satisfy such reporting obligations.

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
     
Exhibit 16.1   Letter of Marcum Asia CPAs LLP dated April 20, 2026

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  POMDOCTOR LIMITED
     
  By: /s/ Zhenyang Shi
  Name:  Zhenyang Shi
  Title: Chairman and Chief Executive Officer

 

Date: April 20, 2026

 

3

 

Filing Exhibits & Attachments

1 document